Early Access

10-QPeriod: Q1 FY2017

SYNOPSYS INC Quarterly Report for Q1 Ended Jan 31, 2017

Filed February 17, 2017For Securities:SNPS

Summary

Synopsys Inc. (SNPS) reported solid financial results for the quarter ending January 31, 2017, demonstrating year-over-year revenue growth of 15% to $652.8 million. This growth was primarily driven by an increase in hardware sales, time-based license revenues, and IP consulting projects, with acquisitions contributing to a lesser extent. Despite increased operating expenses primarily due to higher headcount (including from acquisitions) and increased product and consulting costs, operating income saw a significant rise of 36% to $96.9 million. The company maintained a strong liquidity position with cash, cash equivalents, and short-term investments totaling $966.4 million, though this represented a decrease from the prior quarter due to significant cash outflows for acquisitions and stock repurchases. The company's business model, with approximately 90% of revenue recurring via time-based licenses and maintenance, continues to provide a stable revenue base.

Financial Statements
Beta
Revenue$652.79M
Cost of Revenue$155.75M
Gross Profit$497.04M
R&D Expenses$212.65M
Operating Expenses$400.17M
Operating Income$96.87M
Interest Expense$1.31M
Net Income$86.59M
EPS (Basic)$0.57
EPS (Diluted)$0.56
Shares Outstanding (Basic)150.78M
Shares Outstanding (Diluted)154.43M

Key Highlights

  • 1Total revenue increased by 15% year-over-year to $652.8 million.
  • 2Operating income grew significantly by 36% to $96.9 million.
  • 3The company completed acquisitions totaling $188.1 million during the quarter, adding $132.9 million in goodwill and $64.9 million in identifiable intangible assets.
  • 4Cash, cash equivalents, and short-term investments stood at $966.4 million, down from $1.117 billion at the end of the previous fiscal year, primarily due to cash used in investing and financing activities.
  • 5The company initiated a restructuring plan, recording $12.1 million in charges during the quarter, with a total expected cost of $15-16 million.
  • 6Synopsys amended and restated its credit agreement, increasing its revolving credit facility to $650 million and adding a $150 million term loan facility.
  • 7Diluted earnings per share increased to $0.56 from $0.39 in the prior year period.

Frequently Asked Questions